Diagnostics
10 CFOs in Diagnostics
These ten finance executives currently serve as chief financial officers of diagnostics companies and clinical testing laboratories. A reader can learn how diagnostics CFOs approach reimbursement and revenue cycle, test commercialization, capital raising and laboratory operating costs.
Professionals to explore
01—10Abhishek Jain
LinkedInExperience: Executive Vice President, Chief Financial Officer · NeoGenomics Laboratories
Executive Vice President, Chief Financial Officer at NeoGenomics Laboratories since 2026; the profile describes NeoGenomics as a leader in precision oncology testing. Former Chief Financial Officer (2022–2025) and Vice President, Corporate Controller (2021–2022) at CareDx, Inc.
Asma Cherif
LinkedInExperience: Chief Financial Officer · Unilabs
Chief Financial Officer at Unilabs since 2023; the profile describes Unilabs as an international provider of diagnostic services in laboratory, imaging and pathology. Former Chief Financial Officer at Novartis (2021–2023) and Franchise Finance Head Asia Pacific Middle East Africa at Novartis (2019–2020).
Brian Dow
LinkedInExperience: Chief Financial Officer · SAGA Diagnostics
Chief Financial Officer at SAGA Diagnostics since 2025; the profile describes SAGA as focused on the early detection of molecular residual disease (MRD). Former Chief Financial Officer at ProSomnus® Sleep Technologies (2023–2025), Agendia (2020–2023) and Pulse Biosciences (2015–2019).
Erik Swenson
LinkedInExperience: Chief Financial Officer · Mayo Clinic Laboratories
Chief Financial Officer at Mayo Clinic Laboratories since 2026; the profile describes it as a healthcare company that provides testing and diagnostic services. Former Vice President, Chief Financial Officer at Integrated DNA Technologies (2018–2026) and Sr. Global Finance Director - Financial Planning and Analysis at SCIEX (2015–2018).
Jack Percoskie
LinkedInExperience: Chief Financial Officer · Selux Diagnostics, Inc
Chief Financial Officer at Selux Diagnostics, Inc since 2020; the profile describes Selux as a precision diagnostic company. Former Chief Financial Officer at Unimacts Global (2016–2020) and at OEM by QIAGEN (2011–2015), and former VP of Finance at Akorri (2007–2011).
Kevin Feeley
LinkedInExperience: Chief Financial Officer · GeneDx
Chief Financial Officer at GeneDx since 2021; the profile describes GeneDx as a leader in rare disease diagnosis through genomics. Former Chief Financial Officer at BioReference (2016–2021), and the profile also lists SVP, Operations and Head of GeneDx at Sema4 in 2022.
Manan Khokhani
LinkedInExperience: President and CFO · Molbio Diagnostics
President and CFO at Molbio Diagnostics since 2025; the profile describes Molbio as a company that specializes in molecular diagnostics. Former Group Director Finance - Global Functions, Technology Solutions and Customer Solutions at Worley (2023–2025) and Senior Manager Finance at Thermo Fisher Scientific (2017–2020).
Michael Martinson
LinkedInExperience: Chief Financial Officer · Ambry Genetics
Chief Financial Officer at Ambry Genetics since 2015 and Controller there from 2012 to 2015; the profile describes Ambry as delivering genetic testing for hereditary cancer and exome sequencing for rare disease. Former Audit Senior at Squar Milner (2007–2012).
Scott Gillum, MBA
LinkedInExperience: Chief Financial Officer · Vanta Diagnostics
Chief Financial Officer at Vanta Diagnostics since 2025; the profile describes Vanta as providing diagnostic solutions including antibiotic resistance testing, pharmacogenetics and respiratory testing. Former Vice President Enterprise ERP (2023–2025) and Vice President of Finance, Mid America & Southeast Division (2017–2023) at Labcorp.
Valerie Dixon
LinkedInExperience: Chief Financial Officer · Cleveland Diagnostics
Chief Financial Officer at Cleveland Diagnostics since 2026, where the profile says the role leads the company's financial strategy and capital planning to support growth and commercialization. Former Senior Partner at Flagship Pioneering (2025–2026) and Managing Director at Morgan Stanley (2020–2025).
Choose the right perspective
Match the person to your business model, since finance at a large testing laboratory differs from finance at an early-stage company commercializing its first test. Look at each person's earlier roles too, because CFOs who came from banking, from large healthcare companies or from inside the same company bring different strengths.
Questions to take into the conversation
- 01How do you forecast revenue when payer coverage and reimbursement rates for a test are still uncertain?
- 02Which unit economics do you track per test to decide where to invest in lab capacity?
- 03How do you plan capital and runway while a new diagnostic test moves through validation and launch?
Reaching CFOs in Diagnostics
How can I contact one of these CFOs in Diagnostics?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 10 companies, including NeoGenomics Laboratories, Unilabs and SAGA Diagnostics, based on profile data retrieved on October 3, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach CFOs in Diagnostics?
You choose the offer, starting at $5 per person. It includes Instant Expert's 20% fee, so an offer that pays the person $100 costs you $125. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot and may describe past or present roles. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal